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a  b  s  t  r  a  c  t
The  hormone  leptin  is  produced  by  mature  adipocytes  and  plays  an  important  role  in  regulating  food
intake  and  energy  metabolism  through  its interaction  with  the  leptin  receptor.  In addition  to  roles  in
obesity  and  obesity-related  diseases,  leptin  has been  reported  to affect  the  components  and  secretion
of  bile  in  leptin-deﬁcient  mice.  Furthermore,  gallbladder  diseases  such  as cholelithiasis  are known  to  be
associated  with  serum  leptin  concentrations  in  humans.  We  hypothesized  that the  canine  gallbladder  is
a source  of leptin  and that the  leptin  receptor  may  be localized  in the gallbladder,  where  it plays  a role  in
regulating  the  function  of  this  organ.  The  aim  of  this  study  was  to  demonstrate  the  presence  and  expres-
sion  patterns  of leptin  and  its  receptors  in normal  canine  gallbladders  using  reverse  transcriptase-PCR
(RT-PCR)  and  immunohistochemistry.  Clinically  normal  gallbladder  tissue  samples  were  obtained  from
four healthy  beagle  dogs  with  similar  body  condition  scores.  RT-PCR  and sequencing  of  the  ampliﬁed  PCR
products  revealed  the  presence  of  leptin  mRNA  and  its  receptors  in  the gallbladder.  Immunohistochemi-
cal  investigations  demonstrated  the expression  of leptin  and  its  receptors  in  the  luminal  single  columnar
and  tubuloalveolar  glandular  epithelial  cells.  In conclusion,  the results  of  this  study  demonstrated  the
presence  of  leptin  and  its receptors  in  the  gallbladders  of  dogs.  Leptin  and  its receptor  were  both  localized
throughout  the  cytoplasm  of  luminal  and  glandular  epithelial  cells.  These  results  suggested  that  the  gall-
bladder  is  not  only a  source  of leptin,  but  also  a target  of leptin  though  autocrine/paracrine  mechanisms.
The  results  of this  study  could  increase  the  understanding  of  both  the normal  physiological  functions  of
the  gallbladder  and  the  pathophysiological  mechanisms  of  gallbladder  diseases  characterized  by  leptin
system  dysfunction.
©  2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CC. Introduction
The hormone leptin is produced by mature adipocytes and plays
n important role in regulating food intake and energy metabolism
n the hypothalamus (Hirscbberg, 1998; Maffei et al., 1995). Leptin
inds to and activates leptin receptors, which are part of the class-I
ytokine receptor family. Six different isoforms of leptin recep-
ors have been investigated so far, all of which share a common
xtracellular domain. Although most receptors have transmem-
rane and cytoplasmic domains, the ﬁfth isoform (Ob-Re), known
s the soluble isoform, circulates in the blood stream and does not
ave transmembrane and intracellular domains (Wang et al., 1996).
he intracellular domain determines the characteristics of each of
he isoforms. Leptin binds to the extracellular domain of the leptin
∗ Corresponding author.
E-mail address: whkim@snu.ac.kr (W.H. Kim).
ttp://dx.doi.org/10.1016/j.acthis.2016.09.002
065-1281/© 2016 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
receptor. The Ob-Rb isoform has the longest intracellular domain
in addition to functional Janus-activated kinase-2 and signal trans-
ducer and activator of transcription binding sites, which play a role
in signal transduction and transmission (Bjørbæk et al., 1997; Dam
and Jockers, 2013). There is also evidence of signalling by other iso-
forms, such as erbB2, protein tyrosine phosphate 2/extracellular
regulated kinase, and insulin receptor substrate/phosphoinositide
3-kinase (Frühbeck, 2006; Myers, 2004; Schulz and Widmaier,
2006).
Since its discovery by Zhang et al. (1994), leptin and its recep-
tors have been studied as important factors in energy metabolism
and obesity (Clément et al., 1998; Montague et al., 1997). Further-
more, as the presence and distribution of leptin and its receptors
have been reported in several organs and various species, leptin is
thought to be involved in multiple clinical and pathological condi-
tions. To understand the link between leptin and obesity, various
physiological functions of leptin and its receptors have been stud-
ied: leptin expression in the stomach related to food intake in
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Table  1
Oligonucleotide primer sequences used for reverse transcriptase-PCR in this study.
Target gene Accession Number Direction Sequence (5′ to 3)’ Product Size (bp)
Ob NM 001003070.1 Forward
Reverse
ACCGTATGGGTGTCCTTTATCCT
AGAGTGGCTCTGTGGTGTGAGA
63
Ob-R NM 001024634.1 Forward
Reverse
CTTTTGCCTGCTGGAATCTC
TTGCTCCAAAAGCAACAGTG
143
GAPDH NM 001003142.2 Forward
e
CATTGCCCTCAATGACCACT 105
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b: leptin, Ob-R: leptin receptor, GAPDH: glyceraldehyde-3-phosphate dehydrogen
aboratory animals and humans (Bado et al., 1998; Sobhani et al.,
000) and leptin receptor expression in pancreatic -cells related
o anti-obesity effects in laboratory animals (Kieffer et al., 1996).
urthermore, leptin dysregulation could be an important factor in
he pathogenesis of cardiovascular (Wallace et al., 2001), endocrine
Leal-Cerro et al., 1996; Seufert et al., 1999), and neoplastic diseases
Rose et al., 2004).
The gallbladder stores and concentrates bile through the reab-
orption of water and inorganic salts, excreting the resultant
ixture into the intestinal tract (Kierszenbaum and Tres, 2015).
ile acid, one of the components of bile, plays a critical role in
he digestion and absorption of fats and fat-soluble vitamins in
he small intestine. The systemic effect of leptin has been stud-
ed in relation to the physiological mechanisms of the gallbladder,
nd the relationship between leptin and biliary tract diseases
as been revealed in human and laboratory animals. A previous
tudy revealed that intraperitoneal leptin administration in ob/ob
ice induced gallstone formation and cholesterol crystallization
n a dose-dependent manner (Hyogo et al., 2003). Another study
emonstrated enlarged gallbladder volume and decreased contrac-
ility in Ob/Ob mice. Leptin administration in these mice normalizes
allbladder function (Goldblatt et al., 2002; Swartz-Basile et al.,
007). In addition, alteration of serum leptin concentrations or
eptin administration causes gallbladder dysfunction and diseases
Graewin et al., 2008; Sarac et al., 2015)
Although many studies have suggested the relationships and
ffects of leptin on the gallbladder, no study has demonstrated
he secretion of leptin and the localization of the leptin receptor
n the gallbladder. In the present study, we aimed to demonstrate
he presence and expression pattern of leptin and its receptors in
he normal canine gallbladder using reverse transcriptase-PCR (RT-
CR) and immunohistochemistry as a foundation for future studies
n the role of leptin in both normal physiological functions and vari-
us diseases of the gallbladder, such as choleithiasis and gallbladder
ucocele.
. Materials and methods
.1. Gallbladder sample collection
Gallbladder tissue was aseptically harvested from four 2-year-
ld beagle dogs that were euthanized for other experiments that
ere not associated with liver and gallbladder function. This exper-
ment was approved by the Institutional Animal Care and Use
ommittee of Seoul National University (SNU-150423-6). The dogs
ere clinically healthy with body condition scores of 5 or 6, and
ere conﬁrmed to have normal gallbladders before euthanasia
ased on blood analysis, radiography, and ultrasonography. Gall-
ladder tissue was collected immediately after euthanasia and
ivided in two portions. One portion was promptly frozen in liquid
itrogen then stored at −80 ◦C until required for further processing.
he other portion was ﬁxed by immersion in 10% neutral buffered
ormalin overnight at room temperature and subsequently embed-
ed in parafﬁn blocks for immunohistochemical evaluation. AllTCCTTGGAGGCCATGTGGAC
gallbladders were reconﬁrmed to be normal by histopathological
examination.
2.2. RT-PCR
Total RNA was  isolated from gallbladder samples using a Hybrid-
R RNA extraction kit (305-101, GeneAll Biotechnology, Seoul,
Republic of Korea) according to the manufacturer’s instructions.
The concentration of extracted total RNA was  quantiﬁed using
an Implen NanoPhotometer (model 1443, Implen GmbH, Munich,
Germany). Speciﬁcally, 1000 ng of total RNA was used to synthesize
cDNA. cDNA synthesis was performed on PrimeScriptTM 1st strand
cDNA synthesis kits (6110A, Takara Bio, Tokyo, Japan) according to
the manufacturer’s instructions. The synthesized cDNA was stored
at −20 ◦C.
Each DNA template was  ampliﬁed by PCR using a Mastercy-
cler Pro thermal cycler (Eppendorf, Hauppauge, NY). The total
PCR reaction mixture (20 L) contained PCR Premix (i-starTaq,
iNtRON, Sungnam, Republic of Korea), 0.2 M forward and 0.2 M
reverse primers (Standard Oligo, Bioneer, Daejeon, Korea), 1 L of
cDNA, and 17 L of DNase/RNase-free distilled water (UltrapureTM,
ThermoFisher Scientiﬁc, Waltham, MA,  USA). For evaluation of con-
tamination by other DNA, sterile DNase/RNase-free distilled water
was used as a negative control. The primer sequences for canine
leptin and leptin receptors used in this study are shown in Table 1.
These primers for leptin (Fonfara et al., 2011) and its receptors
(Mercati et al., 2014) were reported previously. Ampliﬁed DNA
fragments of the housekeeping gene glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) were used as positive controls to con-
ﬁrm the integrity of the extracted RNA. The PCR conditions used
were as follows: initial denaturation at 94 ◦C (2 min) followed by
35 cycles consisting of denaturation at 94 ◦C (20 s), annealing at
56 ◦C (10 s), extension at 72 ◦C (20 s), and ﬁnal elongation at 72 ◦C.
The PCR products were analysed by electrophoresis on 1.5% agarose
gel (Agarose LE, iNtRON, Sungnam, Republic of Korea). The identity
of the ampliﬁed PCR products was conﬁrmed by DNA cloning and
sequencing.
PCR products speciﬁc for canine leptin and leptin receptors were
conﬁrmed by cloning and sequencing. Puriﬁcation and extraction
of the ampliﬁed PCR products from 1.5% TAE agarose gels was
conducted using PureLinkTM Quick Gel Extraction and Puriﬁcation
Combo kits (K220001, Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. The products were then ligated into
the vector using an All in OneTM PCR Cloning kit (Biofact, Daejeon,
Republic of Korea), cloned into Escherichia coli DH5, and subse-
quently sequenced.
2.3. Immunohistochemistry
Protein expression of leptin and its receptors was  evaluated by
immunohistochemistry. Four-m thick parafﬁn sections were de-
waxed in xylene two times for 5 min  each and hydrated through a
graded series of ethanol (100% twice, 90%, 80%, 70%, and tap water
for 3 min  each). Sections were incubated with 10-mM citric acid
(pH 6.0) buffer for antigen retrieval using a 2100-retriver pressure
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Fig. 1. (A) Leptin (Ob) and leptin receptor (Ob-R) mRNA expression in the gallbladder of four dogs (1–4) revealed by reverse transcriptase PCR (RT-PCR). The ampliﬁed
products of Ob (63 bp) and Ob-R (143 bp) were observed in the gallbladder of all dogs. The ampliﬁed products of glyceraldehyde 3-phosphate dehydrogenase (105 bp) were
used  as positive controls to conﬁrm the integrity of the extracted RNA. The right-most bands were used to assess the negative controls (N). (B) The nucleotide sequences of
the  ampliﬁed PCR products. Ref Ob and Ref Ob-R indicate the leptin and leptin receptor sequences obtained from the NCBI sequence database. Seq Ob and Seq Ob-R indicate
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The  leptin and leptin receptor sequences obtained using RT-PCR in this study. Each n
he  leptin receptor.
ooker (PickCell Laboratories, Amsterdam, Netherlands) for 20 min.
ndogenous peroxidase activity was quenched by incubating twice
ith peroxidase-blocking (3% hydrogen peroxide) solution for
5 min. Normal horse serum (10% v/v in phosphate-buffered saline)
as applied to sections for 1 h to block non-speciﬁc binding of
he primary antibody. The sections were incubated overnight at
◦C with rabbit polyclonal anti-Ob antibody (1:500; sc-842, Santa
ruz Biotechnology, Santa Cruz, CA, USA), rabbit polyclonal anti-
b-R antibody (1:300; sc-1834-R, Santa Cruz Biotechnology, Santa
ruz, CA, USA), and normal rabbit polyclonal antibody (sc-2027,
anta Cruz Biotechnology, Santa cruz, CA, USA) to serve as a nega-
ive control. The sections were exposed to the secondary antibody
mmPRESSTM HRP Anti-Rabbit IgG (Peroxidase) Polymer Detection
it derived from horse serum (MP-7401, Vector, CA, USA) for 1 h.
hey were visualized using a reaction with 3,3′-diaminobenzidine
etrahydrochloride (ImmPACTTM DAB peroxidase substrate kit,
ector, CA, USA) for 30 s. Counterstaining of the sections was
erformed with Mayer’s Hematoxylin for 1 min. Washing was  per-
ormed between each procedure using Tris Buffered Saline with
.05% Tween 20.
The results of immunostaining were analysed using a light
icroscope (Olympus BX41, Olympus Optical, Tokyo, Japan) con-
ected to a 130-megapixel digital camera (Tomoro ACQUCAM Pro,
echsan Community Co., Korea).tide sequence corresponded exactly to the expected sequences of canine leptin and
3. Results
3.1. RT-PCR
Leptin and leptin receptors were detected in all of the normal
canine gallbladder samples used (Fig. 1A). GAPDH was ampliﬁed
in parallel, while no ampliﬁcation products were detected in any
of the negative control samples. This suggested good RNA integrity
and proper product accumulation for both leptin and its receptors.
3.2. Analysis of ampliﬁed PCR products
The sequence of each cloned ampliﬁed product was  compared
with published sequences of leptin and leptin receptors from
the NCBI (National Center for Biotechnology Information) using
ClustalW. The sequence of each cloned product matched the known
sequences of canine leptin and leptin receptors (Fig. 1B).
3.3. Immunohistochemistry
Immunohistochemistry revealed strong immunoreactivity for
leptin (Fig. 2A) and leptin receptors (Fig. 2C) in the normal canine
gallbladder. Leptin and its receptors were expressed in similar pat-
terns. Strong positive staining for both leptin and the receptors was
located in the cytoplasm of the luminal simple columnar epithe-
lium (arrow in Fig. 2A and C). In addition, immunopositive reactions
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Fig. 2. Leptin (A) and leptin receptor (C) immunohistochemistry in the canine gallbladder. (A)(C) Immunopositive reactions localized in the luminal epithelium (arrow) and
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uclei  (blue) were stained with Mayer’s Hematoxylin. Scale bars = 100 m.  (For int
eb  version of this article.)
ere also present in the tubuloalveolar glands (arrowhead in Fig. 2A
nd C) at the lamina propria-submucosa. However, no speciﬁc reac-
ions for leptin or its receptors were observed in the muscularis and
dventitia or in the negative controls (Fig. 2B and D).
. Discussion
In this study, RT-PCR and immunohistochemistry revealed that
eptin and leptin receptor are localized in the cytoplasm of luminal
nd glandular epithelial cells in the gallbladder, which are both in
irect contact with bile. We  hypothesize that this coexpression of
eptin and its receptor may  imply autocrine/paracrine mechanisms
ithin the gallbladder.
Although leptin binds to and activates leptin receptors on the
urface of cells, the majority of leptin receptors are localized in
ntracellular compartments (Belouzard et al., 2004). Furthermore,
he cytoplasmic immunostaining of leptin receptors in the luminal
nd glandular epithelia demonstrated in this study is in accordance
ith the cytoplasmic localization of leptin receptors in the brain
Couce et al., 1997; De Matteis and Cinti, 1998), adipose tissue
Bornstein et al., 2000), and enterocytes (Barrenetxe et al., 2002),
uggesting that a similar signaling mechanism may  be involved in
hese tissues.
The roles of the gallbladder epithelium are to maintain the
allbladder environment and to regulate the bile components by
ecreting mucin, in addition to secreting and/or reabsorbing water
nd electrolytes. The neck of the gallbladder epithelium contains
ubuloalveolar mucus glands that secrete mucus to create a surface
hat protects the wall of the biliary tree.
Our hypothesis that leptin acts through autocrine/paracrine
echanisms is supported by previous studies. Ob/ob mice have
nlarged volume and decreased contractility of the gallblad-
er (Swartz-Basile et al., 2007). Furthermore, Goldblatt et al.
2002) suggested that leptin may  play a role in regulation of bile in the negative controls used for both leptin (B) and the leptin receptor (D). Cell
ation of the references to colour in this ﬁgure legend, the reader is referred to the
secretion by modulating gallbladder motility. These researchers
demonstrated that leptin-deﬁcient mice have decreased gallblad-
der motility caused by decreased responses to neuropeptide Y,
cholecystokinin, and acetylcholine. Moreover, leptin is involved
in fat metabolism through modulation of bile composition and
gallbladder contraction. A previous study showed that leptin
administration may  inﬂuence regulation of mRNA-encoding genes
involved in bile salt synthesis and transport (Liang and Tall,
2001). However, further studies are needed to elucidate the exact
mechanism underlying the relationship between leptin and fat
metabolism in the gallbladder.
Leptin may  work through an endocrine pathway via leptin
receptor in the gallbladder. This hypothesis is strengthened by
previous research conﬁrming that systemically injected leptin reg-
ulates gallbladder genes involved in transport of water, sodium,
chloride, and bicarbonate, and demonstrating that leptin inﬂuences
gallbladder bile volume and pH in ob/ob mice (Swartz-Basile et al.,
2007). Another study showed that intraperitoneally injected lep-
tin modulated gallbladder genes, including those coding for leptin
receptor, cholecystokinine A receptor, acetylcholine 2 recep-
tor, and Ca+/calmodulin-dependent protein kinase, which are all
related to the pathogenesis of gallstones (Graewin et al., 2008).
Although various gallbladder morbidities have been increas-
ingly researched in small animals, their exact pathogenesis and
etiology are not yet fully understood. Gallbladder dysmotility
results in hypersecretion of mucus and increased water absorption
from bile, which is a main cause of various gallbladder diseases,
including cholelithiasis and mucocele (Doty et al., 1983; Kesimer
et al., 2015; Tsukagoshi et al., 2012). Considering the results of our
study and the fact that gallbladder function is altered according
to presence of leptin (Liang and Tall, 2001; Swartz-Basile et al.,
2007), leptin may  be the key to understand the pathophysiology
of these gallbladder diseases as well as the healthy physiology of
the gallbladder. Interestingly, a relationship between cholelithiasis
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nd serum leptin level also has been observed in patients with this
isease (Sarac et al., 2015).
Although the inﬂuence of leptin on the gallbladder has been
idely suspected and studied, its direct expression in the gall-
ladder has not yet been conﬁrmed. This is a novel ﬁnding of the
urrent study. Leptin has been shown to be produced in several
rgans of the gastrointestinal tract, including the stomach (Bado
t al., 1998; Sobhani et al., 2000) and pancreas (Kieffer et al., 1996),
hile leptin receptors have been demonstrated in the small intes-
ine (Lostao et al., 1998). The ﬁndings of the present study combined
ith these previous reports suggest that digestion and absorp-
ion of fat in the digestive organs may  be regulated systemically
y leptin through endocrine and paracrine/autocrine mechanisms.
owever, further studies are needed to rule out the possibility of
eptin acting through an exocrine mechanism via bile, similar to the
echanism seen in the gastric mucosa (Cammisotto et al., 2005).
One limitation of this study is that the leptin receptor antibody
sed in this study detected all isoforms of leptin receptor, which
ave different and distinct physiologic roles and signal transduc-
ion mechanisms. Further studies concerning the types of leptin
eceptors and their signaling mechanisms in the gallbladder are
equired.
In conclusion, this study demonstrated presence of leptin and
eptin receptor in the gallbladders of dogs. Leptin and its recep-
or were both localized throughout the cytoplasm of luminal and
landular epithelial cells. These results suggest that the gallblad-
er is not only a source of leptin, but also a target of leptin through
utocrine/paracrine mechanisms. These ﬁndings could increase our
nderstanding of the normal physiologic functions of the gallblad-
er as well as the pathophysiologic mechanisms of gallbladder
iseases characterized by leptin system dysfunction.
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